Related Experiment Videos
Scleroderma and malignancy. Mechanisms of interrelationship.
1Department of Dermatology, University of Bonn, Sigmund-Freud-Strasse 25, 53105 Bonn, Germany. joerg.wenzel.ukb.uni-bonn.de
European Journal of Dermatology : EJD
|April 30, 2002
Summary
Recent studies indicate a higher association between scleroderma and malignancy, though the exact reasons remain unclear. This review explores potential links and their implications for both diseases.
Area of Science:
- Rheumatology
- Oncology
- Pathogenesis
Background:
- The relationship between scleroderma and malignancy is debated.
- Previous studies proposed several mechanisms for this association.
- Recent long-term research suggests an increased incidence of malignancy in scleroderma patients.
Purpose of the Study:
- To review proposed mechanisms linking scleroderma and malignancy.
- To discuss the pathogenetic implications for both conditions.
- To clarify the interrelationship between scleroderma and neoplasia.
Main Methods:
- Literature review of earlier studies.
- Analysis of proposed pathogenetic mechanisms.
- Discussion of current evidence and implications.
Main Results:
- Several theoretical mechanisms have been suggested.
- Long-term studies support an increased association ratio.
- Underlying pathogenetic pathways remain largely elusive.
Conclusions:
- The association between scleroderma and malignancy is supported by recent data.
- Further research is needed to elucidate the specific pathogenetic mechanisms.
- Understanding these links is crucial for managing both scleroderma and neoplasia.